AMASS Brands Amends Series C Terms and Draws Additional $2M from Streeterville
AMSS sits 23% above its 52-week low of $0.83 on light trading volume (0.1× avg).
Summary
AMASS Brands amended its Series C Preferred Stock terms and requested an additional $2 million from Streeterville Capital, extending a pattern of highly dilutive financing amid going concern and delisting pressures.
Key Events · Financing and Capital Events · AMSS
-
Series C Terms Amended
Amended and Restated Certificate of Designation filed August 19, 2026, revising liquidation, conversion, redemption, default, and covenant provisions for the 35,000 authorized Series C Preferred shares.
-
Additional $2M Draw Requested
Company delivered a request to Streeterville Capital for purchase of additional Series C Preferred Stock with aggregate purchase price of $2,000,000 under the March 17, 2026 Securities Purchase Agreement.
-
Dilution Risk Escalates
Series C shares carry a stated value of $1,086.96 and convert at the lower of Fixed Price or Market Price (90% of lowest VWAP, floor $0.75), creating significant potential dilution for common holders.
-
Financing Dependence Deepens
This is the latest in a series of Streeterville Capital transactions, including a $6.99M private placement in May and multiple warrant repricings down to $1.50.
Analysis · AMSS · Manufacturing
AMASS Brands has amended the terms of its Series C Convertible Preferred Stock and requested an additional $2 million purchase from Streeterville Capital. The amended certificate revises liquidation, conversion, redemption, and default provisions, while the new draw adds to the company's highly dilutive financing stack. Against a backdrop of a going concern warning, Nasdaq delisting notices, and repeated warrant repricings, this filing deepens the company's dependence on a single toxic financier and increases potential dilution for common shareholders.
At the time of this filing, AMSS was trading at $1.02 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $11.8M. The 52-week trading range was $0.83 to $17.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.